MONONA, Wis. – July 3, 2013 SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has received notice that the Nuclear Regulatory Commission (NRC) has accepted the first part of its Construction Permit application for review and docketing. This is the first formal step by the NRC in the construction permitting process for the SHINE medical isotope facility in Janesville, Wisconsin.
As required by Federal regulations, the Construction Permit application consists of general information about SHINE, an analysis of environmental impacts from the construction and operation of the facility, if any, and a preliminary safety analysis of the planned facility. Today’s acceptance for review and docketing includes the environmental analysis and general and financial information about SHINE; the remaining portions of the preliminary analysis were filed with the NRC on May 31st and will be reviewed for acceptance over the next couple of months.
The NRC’s permitting process is expected to take approximately eighteen months.
“The docketing and acceptance of our application is an important milestone, as it means that the application is of high enough quality for the complete review” said SHINE CEO and founder Greg Piefer.
Based in Janesville, Wisconsin, SHINE deploys its safe, cost-effective and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy and other sectors. SHINE’s proprietary medical isotope production processes create non-carrier-added lutetium-177 and are expected to create molybdenum-99. In the future, SHINE plans to scale its fusion technology to help solve one of energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth. Want to learn more about SHINE? Follow us on social media @shinefusion and sign up for our email newsletter to follow us on our journey!
Media Contact: info@shinefusion.com
